BRILLIANCE trial 2
Credit: OHSU News
Carlene Knight sits outside OHSU’s Casey Eye Institute on April 29, 2021. Knight, who has a genetic form of inherited vision loss, is participating in the BRILLIANCE clinical trial testing an investigational gene-editing treatment designed to repair the mutation and improve vision. (OHSU/Josh Andersen)